Company Filing History:
Years Active: 1999-2005
Title: The Innovative Contributions of Didier Oustric
Introduction
Didier Oustric is a notable inventor based in Le Cres, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cannabinoid receptor antagonists and agonists. With a total of three patents to his name, Oustric's work has implications for immunomodulating drugs and other therapeutic applications.
Latest Patents
Oustric's latest patents include innovative compounds such as 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives, which serve as cannabinoid receptor antagonists. These tricyclic derivatives are designed to interact with cannabinoid CB receptors, providing a method of preparation and pharmaceutical compositions containing them. Another significant patent involves the use of human CB2 receptor-specific agonists for preparing immunomodulating drugs, showcasing his focus on advancing medical treatments through innovative chemical compounds.
Career Highlights
Throughout his career, Didier Oustric has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in drug development and therapeutic solutions.
Collaborations
Oustric has collaborated with notable colleagues such as Francis Barth and Murielle Rinaldi. These partnerships have likely enhanced his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Didier Oustric's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.